BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2158039)

  • 1. Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.
    Keller JR; Ruscetti SK; Ruscetti FW
    Oncogene; 1990 Apr; 5(4):549-55. PubMed ID: 2158039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line.
    Rovera G; Valtieri M; Mavilio F; Reddy EP
    Oncogene; 1987 Mar; 1(1):29-35. PubMed ID: 2449644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral oncogene expression during differentiation of Abelson virus-infected murine promonocytic leukemia cells.
    Hines DL
    Cancer Res; 1988 Apr; 48(7):1702-7. PubMed ID: 2832050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction of growth factor-independence in murine myelocytes by oncogenes results in monoclonal cell lines and is correlated with cell crisis and karyotypic instability.
    Vogt M; Lesley J; Bogenberger JM; Haggblom C; Swift S; Haas M
    Oncogene Res; 1987; 2(1):49-63. PubMed ID: 2851120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of flat revertants isolated from cells transformed by Abelson murine leukemia virus (Ab-MuLV).
    Oka T; Yutsudo M; Inoue H; Higuchi F; Hakura A
    J Cell Physiol; 1990 Dec; 145(3):428-33. PubMed ID: 1703165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
    Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
    J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
    Huntly BJ; Shigematsu H; Deguchi K; Lee BH; Mizuno S; Duclos N; Rowan R; Amaral S; Curley D; Williams IR; Akashi K; Gilliland DG
    Cancer Cell; 2004 Dec; 6(6):587-96. PubMed ID: 15607963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of A-MuLV transformed fibroblast lines for amplification of the c-myc, p53 and c-fos nuclear proto-oncogenes.
    Colledge WH; Gebhardt A; Edge MD; Bell JC
    Oncogene; 1989 Jun; 4(6):753-7. PubMed ID: 2543944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multistage progression of Abelson virus-infected murine pre-B-cells to the tumorigenic state.
    Palumbo GJ; Ozanne BW; Kettman JR
    Cancer Res; 1990 Mar; 50(6):1917-23. PubMed ID: 2155061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms in interleukin-3 regulated growth and differentiation of hematopoietic cells.
    Ihle JN
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1461-74. PubMed ID: 2833844
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoietic and fibroblast cell lines selectively at clinical low dose rate.
    FitzGerald TJ; Henault S; Sakakeeny M; Santucci MA; Pierce JH; Anklesaria P; Kase K; Das I; Greenberger JS
    Radiat Res; 1990 Apr; 122(1):44-52. PubMed ID: 2320725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abrogation of IL-3 dependent growth requires a functional v-src gene product: evidence for an autocrine growth cycle.
    Anderson SM; Carroll PM; Lee FD
    Oncogene; 1990 Mar; 5(3):317-25. PubMed ID: 2107491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines.
    Muljo SA; Schlissel MS
    Nat Immunol; 2003 Jan; 4(1):31-7. PubMed ID: 12469118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.
    Evans CA; Owen-Lynch PJ; Whetton AD; Dive C
    Cancer Res; 1993 Apr; 53(8):1735-8. PubMed ID: 8467488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertional mutagenesis and transformation of hematopoietic stem cells.
    Ihle JN; Morishita K; Matsugi T; Bartholomew C
    Prog Clin Biol Res; 1990; 352():329-37. PubMed ID: 2169632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blast colonies containing hemopoietic progenitor cells can give rise to Abelson virus (A-MuLV)-transformed cell lines.
    Wong PM; Chung SW; Raefsky E; Eaves CJ; Nienhuis AW
    Exp Hematol; 1988 Jan; 16(1):5-11. PubMed ID: 2446900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An E. coli expression system for the rapid purification and characterization of a v-abl tyrosine protein kinase.
    Lydon NB; Adams B; Poschet JF; Gutzwiller A; Matter A
    Oncogene Res; 1990; 5(3):161-73. PubMed ID: 2157186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hemopoietic progenitor 32DCl3(G) cells synthesize C3 molecules and acquire C3b acceptor sites upon differentiation or neoplastic transformation.
    Di Renzo L; Zicari A; Longo A; Realacci M; Naso G; Pontieri G; Lipari M
    J Immunol; 1993 Oct; 151(7):3737-45. PubMed ID: 8376803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.